ANCA-associated vasculitis with dual ANCA positivity in coexistence with mixed connective tissue disease

References

• Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52:148–59.
   Google Scholar
• Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue dis-ease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899–909.
   PubMed Web of Science ®Google Scholar
• Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulo-nephritis. N Engl J Med. 1988;318:1651–7.
   PubMed Web of Science ®Google Scholar
• Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: preva-lence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000;43:405–13.
   PubMed Web of Science ®Google Scholar
• Gregersen PK, Olsson LM. Resent advances in the genetics of autoimmune disease. Annu Rev Immunol. 2009;27:363–91.
   PubMed Web of Science ®Google Scholar
• Dong RP, Kimura A, Hashimoto H, Akizuki M, Nishimura Y, Sasazuki T. Difference in HLA-linked genetic background between mixed connective tissue disease and systemic lupus erythematosus. Tissue Antigens. 1993;41:20–5.
   PubMedGoogle Scholar
• Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M, et al. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: asso-ciation of HLA-DRB1*0901 with microscopic polyangiitis. J Rheumatol. 2003;30:1534–40.
   PubMed Web of Science ®Google Scholar
• Kasukawa R, Tojo T, Miyawaki S, et al. Mixed connective tissue disease-a preliminary diagnostic criteria. Jpn J Rheumatol. 1988;1:263–70.
   Google Scholar
• Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulo-matosis and angiitis). Arthritis Rheum. 1990;33:1094–100.
   PubMed Web of Science ®Google Scholar
• Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101–7.
   PubMed Web of Science ®Google Scholar
• Said G, Lacroix-Ciaudo C, Fujimura H, Blas C, Faux N. The peripheral neuropathy of necrotizing arteritis: a clinicopatholog-ical study. Ann Neurol. 1988;23:461–5.
   PubMed Web of Science ®Google Scholar
• Cattaneo L, Chierici E, Pavone L, Grasselli C, Manganelli P, Buzio C, et al. Peripheral neuropathy in Wegener's granuloma-tosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatry. 2007;78:1119–23.
   PubMed Web of Science ®Google Scholar
• Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vascu-litis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998;53:743–53.
   PubMed Web of Science ®Google Scholar
• Guillevin L, Lhote F. Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment. Curr Opin Rheumatol. 1995;7:20–4.
   PubMedGoogle Scholar
• Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-asso-ciated vasculitis. N Engl J Med. 2010;363:221–32.
   PubMed Web of Science ®Google Scholar
• Guardiola JM, Rodriguez-Pla A, Lopez-Contreras J, Llobet JM, Domingo P, Franco M, et al. Simultaneous presence of C-ANCA and P-ANCA in a patient with concurrent Churg-Strauss syn-drome and giant cell temporal arteritis. Scand J Rheumatol. 2000;29:68–9.
   PubMed Web of Science ®Google Scholar
• Ueda H, Ishimura E, Yunoki T, Tsuchida T, Matsumoto N, Jono S, et al. Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA. Clin Exp Nephrol. 2005;9:332–4.
   PubMedGoogle Scholar
• Ferraz-Amaro I, Herrero MJ, Jurado A, Diaz-Gonzalez F. Dual positivity for cytoplasmic and perinuclear anti-neutrophil anti-bodies in a patient with Henoch-Schonlein purpura. Clin Exp Rheumatol. 2004;22:233–4.
   Google Scholar
• Tiliakos AM, Tiliakos NA. Dual ANCA positivity in subacute bacterial endocarditis. J Clin Rheumatol. 2008;14:38–40.
   PubMed Web of Science ®Google Scholar
• Meisels IS, Stillman IE, Kuhlik AB. Anti-glomerular basement membrane disease and dual positivity for antineutrophil cyto-plasmic antibody in a patient with membranous nephropathy. Am J Kidney Dis. 1998;32:646–8.
   Google Scholar
• Sakalli H, Baskin E, Alehan F, Agildere M, Akova YA, Caner H. Dual anca positivity in a child with moyamoya-like cerebral vascular changes: an unusual presentation with sudden homony-mous hemianopsia. Rheumatol Int. 2011 (Epub ahead of print).
   Google Scholar
• Makita N, Katori H, Takemoto F, Yokota M, Kitamura Y, Ubara Y, et al. A case of mixed connective tissue disease (MCTD) complicated with MPO-ANCA-related necrotizing glomerulone-phritis. Clin Nephrol. 2000;54:164–8.
   PubMed Web of Science ®Google Scholar
• Kanazawa M, Wada Y, Ohno T, In H, Yahata K, Izumi J, et al. Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis: a case report. Clin Rheumatol. 2004;23:456–9.
   PubMed Web of Science ®Google Scholar
• Hernandez-Molina G, Reyes E, Crispin JC. ANCA associated glomerulonephritis in a patient with mixed connective tissue disease. Ann Rheum Dis. 2006;65:410–1.
   Google Scholar
• Kitaura K, Miyagawa T, Asano K, Oouchi S, Mild T, Fujisawa T, et al. Mixed connective tissue disease associated with MPO-ANCA-positive polyangiitis. Intern Med. 2006;45:1177–82.
   PubMed Web of Science ®Google Scholar
• Murakami T, Endo S, Moriki T, Doi T, Matsumoto Y. Mixed connective tissue disease developing into MPO-ANCA-positive polyangiitis. Intern Med. 2011;50:591–6.
   Google Scholar
• Franssen C, Gans R, Kallenberg C, Hageluken C, Hoorntje S. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase auto-antibodies. J Intern Med. 1998;244: 209–16.
   Google Scholar
• Pradhan VD, Badakere SS, Pawar AR, Almeida AF. Anti-mye-loperoxidase antibodies in patients with microscopic polyangiitis. Indian J Med Sci. 2003;57:479–86.
   PubMedGoogle Scholar
• Japanese Society for Histocompany Histocompatibility and Immunogenetics. http://jshi.umin.ac.jp/databank/jap-allele.html (in Japanese).
   Google Scholar
• Kawabata Y, Ikegami H, Kawaguchi Y, Fujisawa T, Shintani M, Ono M, et al. Asian-specific HLA haplotypes reveal hetero-geneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes. 2002;51:545–51.
   PubMed Web of Science ®Google Scholar
• Matsuki K, Juji T, Tokunaga K, Takamizawa M, Maeda H, Soda M, et al. HLA antigens in Japanese patients with myasthenia gravis. J Clin Invest. 1990;86:392–9.
   PubMed Web of Science ®Google Scholar
• Kochi Y, Yamada R, Kobayashi K, Takahashi A, Suzuki A, Sekine A, et al. Analysis of single-nucleotide polymorphisms in Japanese rheumatoid arthritis patients shows additional suscep-tibility markers besides the classic shared epitope susceptibility sequences. Arthritis Rheum. 2004;50:63–71.
   PubMed Web of Science ®Google Scholar
• Tsuchiya N, Kobayashi S, Hashimoto H, Ozaki S, Tokunaga K. Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese. Genes Immun. 2006;7: 81–5.
   Google Scholar
• Nakamaru Y, Maguchi S, Takizawa M, Fukuda S, Inuyama Y. The association between human leukocyte antigens (HLA) and cytoplasmic-antineutrophil cytoplasmic antibody (cANCA)-positive Wegener's granulomatosis in a Japanese population. Rhinology. 1996;34:163–5.
   Google Scholar
• Hong GH, Kim HY, Takeuchi F, Nakano K, Yamada H, Matsuta K, et al. Association of complement C4 and HLA-DR alleles with systemic lupus erythematosus in Koreans. J Rheumatol. 1994;21: 442–7.
   PubMed Web of Science ®Google Scholar
• Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, edi-tors. HLA 1991, vol. 1. Oxford: Oxford University Press; 1992. p. 1065–220.
   Google Scholar
• Nomura S, Matsuzaki T, Ozaki Y, Yamaoka M, Yoshimura C, Katsura K, et al. Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura. Blood. 1998;91:3616–22.
   PubMed Web of Science ®Google Scholar
• Horiki T, Ichikawa Y, Moriuchi J, Hoshina Y, Yamada C, Wakabayashi T, et al. HLA class II haplotypes associated with pulmonary interstitial lesions of polymyositis/dermatomyositis in Japanese patients. Tissue Antigens. 2002;59:25–30.
   PubMedGoogle Scholar
• Matsushita T, Matsuoka T, Isobe N, Kawano Y, Minohara M, Shi N, et al. Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idio-pathic central nervous system demyelinating disorders. Tissue Antigens. 2009;73:171–6.
   PubMedGoogle Scholar